MERILOG 100 [iU]/mL
insulin aspart-szjj · INJECTION, SOLUTION · Sanofi-Aventis U.S. LLC
Merilog (Insulin Aspart-Szjj) is a fast-acting insulin medication used to help control blood sugar levels in people with diabetes. It is given as an intravenous injection and works by replacing or supplementing the insulin your body needs to regulate glucose.
Key Facts
- Brand Name
- MERILOG
- Generic Name
- insulin aspart-szjj
- NDC Code (Product)
0024-5928- Manufacturer
- Sanofi-Aventis U.S. LLC
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761325
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 02/14/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is MERILOG used for?
Merilog (Insulin Aspart-Szjj) is a fast-acting insulin medication used to help control blood sugar levels in people with diabetes. It is given as an intravenous injection and works by replacing or supplementing the insulin your body needs to regulate glucose.
Is MERILOG a controlled substance?
MERILOG is not classified as a controlled substance by the DEA.
What is the generic name for MERILOG?
The generic name for MERILOG is insulin aspart-szjj. There are no other listed brand versions of insulin aspart-szjj.
What is the NDC code for MERILOG 100 [iU]/mL?
The NDC (National Drug Code) for MERILOG 100 [iU]/mL is 0024-5928, listed by Sanofi-Aventis U.S. LLC.
Other MERILOG Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)